Myrexis (MYRX) Presents Two Posters for MPC-9528; To File IND with U.S. FDA by End of FY11
Tweet Send to a Friend
Myrexis, Inc. (Nasdaq: MYRX) announced that they presented two posters for MPC-9528.
MPC-9528 exhibited superior potency in enzymatic, cellular ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
MPC-9528 exhibited superior potency in enzymatic, cellular ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
